Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.

Biden's office said Sunday that he has been diagnosed with aggressive prostate cancer and is reviewing treatment options.